| 发明名称 |
CO -ADMINISTRATION OF ERIBULIN AND FARLETUZUMAB FOR THE TREATMENT OF BREAST CANCER |
| 摘要 |
The present invention provides methods for treating a subject having breast cancer by administering (a) eribulin or a pharmaceutically acceptable salt thereof, and (b) farletuzumab or an antigen-binding fragment thereof. |
| 申请公布号 |
WO2012119077(A1) |
申请公布日期 |
2012.09.07 |
| 申请号 |
WO2012US27488 |
申请日期 |
2012.03.02 |
| 申请人 |
MORPHOTEK INC.;MALTZMAN, JULIA, D. |
发明人 |
MALTZMAN, JULIA, D. |
| 分类号 |
A61K31/357;A61K39/395;A61P35/00 |
主分类号 |
A61K31/357 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
